ATProto Browser

Record data

{
  "uri": "at://did:plc:d56idxm2oyqwwn2uxnegm2yo/app.bsky.feed.post/3lpeavpdmak2c",
  "cid": "bafyreid6q4atwgr5aedq7rxnyu2hqasfxry77xjoctziz3yyubyvqevirm",
  "value": {
    "text": "Guardian writers campaigned against puberty-blockers because they were prescribed \"off label\".\n\nNow the Guardian is celebrating Ozempic, a drug being used off label for obesity.\n\nThe difference...?\n\nPuberty-blockers have been used for trans kids for 30+ years, Ozempic for obesity only for 4 years.",
    "$type": "app.bsky.feed.post",
    "embed": {
      "$type": "app.bsky.embed.images",
      "images": [
        {
          "alt": "Gamechanger for more than just obesity\nFirst developed to help lower blood sugar levels as a diabetes treatment, it was quickly apparent that Novo Nordisk’s drug semaglutide (the active ingredient in Ozempic and Wegovy jabs) has a dramatic effect on weight. The drug works by mimicking a hormone, GLP-1, which is released in the gut when we eat and acts on receptors around the body, including the brain.",
          "image": {
            "$type": "blob",
            "ref": {
              "$link": "bafkreib3q4lcedpbjw2wfwomiwlaxbarnbxbze2boo6yi55aevhxqwqmka"
            },
            "mimeType": "image/jpeg",
            "size": 91981
          },
          "aspectRatio": {
            "width": 774,
            "height": 178
          }
        }
      ]
    },
    "langs": [
      "en"
    ],
    "createdAt": "2025-05-17T09:42:24.672Z"
  }
}